Big Data, Hidden Knowledge
Novel mathematical tools show promise in predicting ovarian cancer patient survival and sensitivity to platinum-based chemotherapy.
By Fedra Pavlou
At a Glance
- Most ovarian cancer cases are diagnosed in advanced stages, and no diagnostic exists that distinguishes tumors that are resistant to traditional chemotherapy from those that aren’t
- A team based at the University of Utah have developed a mathematical tool that analyzes DNA profiles from the Cancer Genome Atlas to discover patterns of DNA anomalies
- Using this approach, they have been able to predict a woman’s outcome significantly better than can be done with the tumor’s stage; it is also the first known indicator of how well a woman will respond to platinum therapy
- These DNA patterns could be the basis of a personalized prognostic and diagnostic laboratory test. The researchers continue to assess the patterns in ovarian cancer and plan to expand their mathematical modeling to other tumor types
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
If you don’t have an account you can:
REGISTER NOW – it’s FREE and always will be!
You will benefit from:
- Unlimited access to ALL articles including Application Notes
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login as a Guest or via Social Media
This will allow you to read this article but you will only have limited access to The Pathologist.Login as Guest Facebook Google+ LinkedIn Twitter